HashiCorp, Inc.

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, MSFT has a market cap of 3.9T. Regarding current trading prices, HCP is priced at $34.78, while MSFT trades at $522.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas MSFT's P/E ratio is 38.14. In terms of profitability, HCP's ROE is -0.07%, compared to MSFT's ROE of +0.32%. Regarding short-term risk, HCP is less volatile compared to MSFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MSFT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ORCL has a market cap of 697.6B. Regarding current trading prices, HCP is priced at $34.78, while ORCL trades at $244.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ORCL's P/E ratio is 57.22. In terms of profitability, HCP's ROE is -0.07%, compared to ORCL's ROE of +0.81%. Regarding short-term risk, HCP is less volatile compared to ORCL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ORCL's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PLTR has a market cap of 402.8B. Regarding current trading prices, HCP is priced at $34.78, while PLTR trades at $181.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PLTR's P/E ratio is 571.39. In terms of profitability, HCP's ROE is -0.07%, compared to PLTR's ROE of +0.15%. Regarding short-term risk, HCP is less volatile compared to PLTR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLTR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ADBE has a market cap of 150.5B. Regarding current trading prices, HCP is priced at $34.78, while ADBE trades at $348.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ADBE's P/E ratio is 22.72. In terms of profitability, HCP's ROE is -0.07%, compared to ADBE's ROE of +0.52%. Regarding short-term risk, HCP is less volatile compared to ADBE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ADBE's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PANW has a market cap of 118.2B. Regarding current trading prices, HCP is priced at $34.78, while PANW trades at $173.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PANW's P/E ratio is 102.36. In terms of profitability, HCP's ROE is -0.07%, compared to PANW's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to PANW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PANW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SNPS has a market cap of 114.3B. Regarding current trading prices, HCP is priced at $34.78, while SNPS trades at $616.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SNPS's P/E ratio is 71.35. In terms of profitability, HCP's ROE is -0.07%, compared to SNPS's ROE of +0.24%. Regarding short-term risk, HCP is less volatile compared to SNPS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SNPS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWD has a market cap of 106.7B. Regarding current trading prices, HCP is priced at $34.78, while CRWD trades at $424.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CRWD's P/E ratio is -629.26. In terms of profitability, HCP's ROE is -0.07%, compared to CRWD's ROE of -0.05%. Regarding short-term risk, HCP is less volatile compared to CRWD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, HOOD has a market cap of 101.5B. Regarding current trading prices, HCP is priced at $34.78, while HOOD trades at $110.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas HOOD's P/E ratio is 57.95. In terms of profitability, HCP's ROE is -0.07%, compared to HOOD's ROE of +0.23%. Regarding short-term risk, HCP is less volatile compared to HOOD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check HOOD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NET has a market cap of 70B. Regarding current trading prices, HCP is priced at $34.78, while NET trades at $195.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NET's P/E ratio is -608.82. In terms of profitability, HCP's ROE is -0.07%, compared to NET's ROE of -0.10%. Regarding short-term risk, HCP is less volatile compared to NET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NET's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, HCP is priced at $34.78, while VMW trades at $142.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas VMW's P/E ratio is 42.92. In terms of profitability, HCP's ROE is -0.07%, compared to VMW's ROE of +3.99%. Regarding short-term risk, HCP is less volatile compared to VMW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VMW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FTNT has a market cap of 60.6B. Regarding current trading prices, HCP is priced at $34.78, while FTNT trades at $77.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FTNT's P/E ratio is 31.52. In terms of profitability, HCP's ROE is -0.07%, compared to FTNT's ROE of +1.21%. Regarding short-term risk, HCP is less volatile compared to FTNT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FTNT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, HCP is priced at $34.78, while SQ trades at $83.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SQ's P/E ratio is 49.98. In terms of profitability, HCP's ROE is -0.07%, compared to SQ's ROE of +0.13%. Regarding short-term risk, HCP is less volatile compared to SQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWV has a market cap of 48.1B. Regarding current trading prices, HCP is priced at $34.78, while CRWV trades at $99.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CRWV's P/E ratio is -42.36. In terms of profitability, HCP's ROE is -0.07%, compared to CRWV's ROE of -0.51%. Regarding short-term risk, HCP is less volatile compared to CRWV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWV's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, XYZ has a market cap of 46.2B. Regarding current trading prices, HCP is priced at $34.78, while XYZ trades at $76.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas XYZ's P/E ratio is 16.20. In terms of profitability, HCP's ROE is -0.07%, compared to XYZ's ROE of +0.14%. Regarding short-term risk, HCP is less volatile compared to XYZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check XYZ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ZS has a market cap of 42.8B. Regarding current trading prices, HCP is priced at $34.78, while ZS trades at $270.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ZS's P/E ratio is -1017.89. In terms of profitability, HCP's ROE is -0.07%, compared to ZS's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to ZS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, HCP is priced at $34.78, while NETE trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NETE's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.07%, compared to NETE's ROE of -1.70%. Regarding short-term risk, HCP is less volatile compared to NETE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NETE's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, HCP is priced at $34.78, while SPLK trades at $156.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SPLK's P/E ratio is 103.22. In terms of profitability, HCP's ROE is -0.07%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, HCP is more volatile compared to SPLK. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SPLK's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AFRM has a market cap of 25.4B. Regarding current trading prices, HCP is priced at $34.78, while AFRM trades at $77.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AFRM's P/E ratio is -414.32. In terms of profitability, HCP's ROE is -0.07%, compared to AFRM's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to AFRM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AFRM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, VRSN has a market cap of 25.2B. Regarding current trading prices, HCP is priced at $34.78, while VRSN trades at $266.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas VRSN's P/E ratio is 32.24. In terms of profitability, HCP's ROE is -0.07%, compared to VRSN's ROE of -0.50%. Regarding short-term risk, HCP is less volatile compared to VRSN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRSN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TOST has a market cap of 25.2B. Regarding current trading prices, HCP is priced at $34.78, while TOST trades at $43.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TOST's P/E ratio is 110.62. In terms of profitability, HCP's ROE is -0.07%, compared to TOST's ROE of +0.14%. Regarding short-term risk, HCP is less volatile compared to TOST. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TOST's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CPAY has a market cap of 22.4B. Regarding current trading prices, HCP is priced at $34.78, while CPAY trades at $320.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CPAY's P/E ratio is 21.60. In terms of profitability, HCP's ROE is -0.07%, compared to CPAY's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to CPAY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CPAY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, HCP is priced at $34.78, while FLT trades at $303.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FLT's P/E ratio is 22.97. In terms of profitability, HCP's ROE is -0.07%, compared to FLT's ROE of +0.33%. Regarding short-term risk, HCP is less volatile compared to FLT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FLT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CYBR has a market cap of 21.4B. Regarding current trading prices, HCP is priced at $34.78, while CYBR trades at $414.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CYBR's P/E ratio is -120.41. In terms of profitability, HCP's ROE is -0.07%, compared to CYBR's ROE of -0.08%. Regarding short-term risk, HCP is less volatile compared to CYBR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CYBR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CHKP has a market cap of 20.5B. Regarding current trading prices, HCP is priced at $34.78, while CHKP trades at $185.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CHKP's P/E ratio is 24.63. In terms of profitability, HCP's ROE is -0.07%, compared to CHKP's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to CHKP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CHKP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GDDY has a market cap of 20.2B. Regarding current trading prices, HCP is priced at $34.78, while GDDY trades at $143.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GDDY's P/E ratio is 26.06. In terms of profitability, HCP's ROE is -0.07%, compared to GDDY's ROE of +1.47%. Regarding short-term risk, HCP is less volatile compared to GDDY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GDDY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GEN has a market cap of 19.4B. Regarding current trading prices, HCP is priced at $34.78, while GEN trades at $31.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GEN's P/E ratio is 32.78. In terms of profitability, HCP's ROE is -0.07%, compared to GEN's ROE of +0.27%. Regarding short-term risk, HCP is less volatile compared to GEN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GEN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, IOT has a market cap of 19.1B. Regarding current trading prices, HCP is priced at $34.78, while IOT trades at $32.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas IOT's P/E ratio is -152.36. In terms of profitability, HCP's ROE is -0.07%, compared to IOT's ROE of -0.12%. Regarding short-term risk, HCP is less volatile compared to IOT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check IOT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NTNX has a market cap of 18.4B. Regarding current trading prices, HCP is priced at $34.78, while NTNX trades at $68.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NTNX's P/E ratio is -264.15. In terms of profitability, HCP's ROE is -0.07%, compared to NTNX's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to NTNX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTNX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FFIV has a market cap of 18.1B. Regarding current trading prices, HCP is priced at $34.78, while FFIV trades at $318.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FFIV's P/E ratio is 27.81. In terms of profitability, HCP's ROE is -0.07%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to FFIV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FFIV's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, KSPI has a market cap of 18.1B. Regarding current trading prices, HCP is priced at $34.78, while KSPI trades at $95.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas KSPI's P/E ratio is 9.09. In terms of profitability, HCP's ROE is -0.07%, compared to KSPI's ROE of +0.75%. Regarding short-term risk, HCP is less volatile compared to KSPI. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KSPI's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, MDB has a market cap of 17.8B. Regarding current trading prices, HCP is priced at $34.78, while MDB trades at $204.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas MDB's P/E ratio is -202.09. In terms of profitability, HCP's ROE is -0.07%, compared to MDB's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to MDB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MDB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RBRK has a market cap of 16.6B. Regarding current trading prices, HCP is priced at $34.78, while RBRK trades at $84.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RBRK's P/E ratio is 24.75. In terms of profitability, HCP's ROE is -0.07%, compared to RBRK's ROE of +0.99%. Regarding short-term risk, HCP is less volatile compared to RBRK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RBRK's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, OKTA has a market cap of 15.4B. Regarding current trading prices, HCP is priced at $34.78, while OKTA trades at $88.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas OKTA's P/E ratio is 141.57. In terms of profitability, HCP's ROE is -0.07%, compared to OKTA's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to OKTA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check OKTA's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, HCP is priced at $34.78, while NLOK trades at $21.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NLOK's P/E ratio is 15.15. In terms of profitability, HCP's ROE is -0.07%, compared to NLOK's ROE of +0.30%. Regarding short-term risk, HCP is less volatile compared to NLOK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NLOK's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SAIL has a market cap of 11.4B. Regarding current trading prices, HCP is priced at $34.78, while SAIL trades at $19.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SAIL's P/E ratio is -12.56. In terms of profitability, HCP's ROE is -0.07%, compared to SAIL's ROE of -0.13%. Regarding short-term risk, HCP is less volatile compared to SAIL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SAIL's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AKAM has a market cap of 10.7B. Regarding current trading prices, HCP is priced at $34.78, while AKAM trades at $74.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AKAM's P/E ratio is 26.30. In terms of profitability, HCP's ROE is -0.07%, compared to AKAM's ROE of +0.09%. Regarding short-term risk, HCP is less volatile compared to AKAM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AKAM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DOX has a market cap of 9.7B. Regarding current trading prices, HCP is priced at $34.78, while DOX trades at $87.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DOX's P/E ratio is 17.68. In terms of profitability, HCP's ROE is -0.07%, compared to DOX's ROE of +0.16%. Regarding short-term risk, HCP is less volatile compared to DOX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while ALTR trades at $111.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ALTR's P/E ratio is 699.06. In terms of profitability, HCP's ROE is -0.07%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, HCP is more volatile compared to ALTR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check ALTR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while PLAN trades at $63.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PLAN's P/E ratio is -44.82. In terms of profitability, HCP's ROE is -0.07%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, HCP is less volatile compared to PLAN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLAN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, KVYO has a market cap of 9.4B. Regarding current trading prices, HCP is priced at $34.78, while KVYO trades at $31.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas KVYO's P/E ratio is -130.97. In terms of profitability, HCP's ROE is -0.07%, compared to KVYO's ROE of -0.06%. Regarding short-term risk, HCP is less volatile compared to KVYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KVYO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FOUR has a market cap of 8.2B. Regarding current trading prices, HCP is priced at $34.78, while FOUR trades at $89.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FOUR's P/E ratio is 34.17. In terms of profitability, HCP's ROE is -0.07%, compared to FOUR's ROE of +0.26%. Regarding short-term risk, HCP is less volatile compared to FOUR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FOUR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, HCP is priced at $34.78, while INFA trades at $24.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas INFA's P/E ratio is -824.17. In terms of profitability, HCP's ROE is -0.07%, compared to INFA's ROE of -0.00%. Regarding short-term risk, HCP is less volatile compared to INFA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check INFA's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DBX has a market cap of 7.5B. Regarding current trading prices, HCP is priced at $34.78, while DBX trades at $27.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DBX's P/E ratio is 17.07. In terms of profitability, HCP's ROE is -0.07%, compared to DBX's ROE of -0.53%. Regarding short-term risk, HCP is less volatile compared to DBX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DBX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, WIX has a market cap of 6.9B. Regarding current trading prices, HCP is priced at $34.78, while WIX trades at $120.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas WIX's P/E ratio is 43.94. In terms of profitability, HCP's ROE is -0.07%, compared to WIX's ROE of -1.18%. Regarding short-term risk, HCP is less volatile compared to WIX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WIX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, HCP is priced at $34.78, while JCOM trades at $142.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas JCOM's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.07%, compared to JCOM's ROE of +0.12%. Regarding short-term risk, HCP is less volatile compared to JCOM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check JCOM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, VRNS has a market cap of 6.5B. Regarding current trading prices, HCP is priced at $34.78, while VRNS trades at $56.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas VRNS's P/E ratio is -63.49. In terms of profitability, HCP's ROE is -0.07%, compared to VRNS's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to VRNS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRNS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, HCP is priced at $34.78, while SQSP trades at $46.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, HCP's ROE is -0.07%, compared to SQSP's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to SQSP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQSP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CCCS has a market cap of 6.3B. Regarding current trading prices, HCP is priced at $34.78, while CCCS trades at $9.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CCCS's P/E ratio is 971.00. In terms of profitability, HCP's ROE is -0.07%, compared to CCCS's ROE of +0.00%. Regarding short-term risk, HCP is less volatile compared to CCCS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CCCS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, HCP is priced at $34.78, while NEWR trades at $86.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NEWR's P/E ratio is -41.62. In terms of profitability, HCP's ROE is -0.07%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, HCP is more volatile compared to NEWR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NEWR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CFLT has a market cap of 6.1B. Regarding current trading prices, HCP is priced at $34.78, while CFLT trades at $17.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CFLT's P/E ratio is -19.13. In terms of profitability, HCP's ROE is -0.07%, compared to CFLT's ROE of -0.31%. Regarding short-term risk, HCP is less volatile compared to CFLT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CFLT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, WEX has a market cap of 6B. Regarding current trading prices, HCP is priced at $34.78, while WEX trades at $175.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas WEX's P/E ratio is 22.06. In terms of profitability, HCP's ROE is -0.07%, compared to WEX's ROE of +0.25%. Regarding short-term risk, HCP is less volatile compared to WEX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WEX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PATH has a market cap of 5.9B. Regarding current trading prices, HCP is priced at $34.78, while PATH trades at $10.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PATH's P/E ratio is -91.42. In terms of profitability, HCP's ROE is -0.07%, compared to PATH's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to PATH. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PATH's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, S has a market cap of 5.3B. Regarding current trading prices, HCP is priced at $34.78, while S trades at $16.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas S's P/E ratio is -12.72. In terms of profitability, HCP's ROE is -0.07%, compared to S's ROE of -0.26%. Regarding short-term risk, HCP is less volatile compared to S. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check S's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, HCP is priced at $34.78, while NVEI trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NVEI's P/E ratio is 212.44. In terms of profitability, HCP's ROE is -0.07%, compared to NVEI's ROE of +0.01%. Regarding short-term risk, HCP is more volatile compared to NVEI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NVEI's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ACIW has a market cap of 4.8B. Regarding current trading prices, HCP is priced at $34.78, while ACIW trades at $46.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ACIW's P/E ratio is 19.73. In terms of profitability, HCP's ROE is -0.07%, compared to ACIW's ROE of +0.18%. Regarding short-term risk, HCP is less volatile compared to ACIW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ACIW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, QLYS has a market cap of 4.7B. Regarding current trading prices, HCP is priced at $34.78, while QLYS trades at $129.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas QLYS's P/E ratio is 25.73. In terms of profitability, HCP's ROE is -0.07%, compared to QLYS's ROE of +0.38%. Regarding short-term risk, HCP is less volatile compared to QLYS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check QLYS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, BOX has a market cap of 4.6B. Regarding current trading prices, HCP is priced at $34.78, while BOX trades at $31.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas BOX's P/E ratio is 24.31. In terms of profitability, HCP's ROE is -0.07%, compared to BOX's ROE of +1.97%. Regarding short-term risk, HCP is less volatile compared to BOX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BOX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DLO has a market cap of 4.5B. Regarding current trading prices, HCP is priced at $34.78, while DLO trades at $15.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DLO's P/E ratio is 32.63. In terms of profitability, HCP's ROE is -0.07%, compared to DLO's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to DLO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DLO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZZ has a market cap of 4.4B. Regarding current trading prices, HCP is priced at $34.78, while CORZZ trades at $13.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CORZZ's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.07%, compared to CORZZ's ROE of +1.54%. Regarding short-term risk, HCP is less volatile compared to CORZZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZZ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZ has a market cap of 4.3B. Regarding current trading prices, HCP is priced at $34.78, while CORZ trades at $13.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CORZ's P/E ratio is -8.17. In terms of profitability, HCP's ROE is -0.07%, compared to CORZ's ROE of +1.54%. Regarding short-term risk, HCP is less volatile compared to CORZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SPSC has a market cap of 4.2B. Regarding current trading prices, HCP is priced at $34.78, while SPSC trades at $113.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SPSC's P/E ratio is 51.39. In terms of profitability, HCP's ROE is -0.07%, compared to SPSC's ROE of +0.09%. Regarding short-term risk, HCP is less volatile compared to SPSC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SPSC's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RELY has a market cap of 4B. Regarding current trading prices, HCP is priced at $34.78, while RELY trades at $19.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RELY's P/E ratio is 326.67. In terms of profitability, HCP's ROE is -0.07%, compared to RELY's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to RELY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RELY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, STNE has a market cap of 4B. Regarding current trading prices, HCP is priced at $34.78, while STNE trades at $15.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas STNE's P/E ratio is -22.26. In terms of profitability, HCP's ROE is -0.07%, compared to STNE's ROE of -0.10%. Regarding short-term risk, HCP is less volatile compared to STNE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STNE's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EEFT has a market cap of 3.9B. Regarding current trading prices, HCP is priced at $34.78, while EEFT trades at $96.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EEFT's P/E ratio is 13.24. In terms of profitability, HCP's ROE is -0.07%, compared to EEFT's ROE of +0.25%. Regarding short-term risk, HCP is less volatile compared to EEFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EEFT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, HCP is priced at $34.78, while ESMT trades at $23.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ESMT's P/E ratio is 153.67. In terms of profitability, HCP's ROE is -0.07%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to ESMT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ESMT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CLBT has a market cap of 3.7B. Regarding current trading prices, HCP is priced at $34.78, while CLBT trades at $15.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CLBT's P/E ratio is -21.67. In terms of profitability, HCP's ROE is -0.07%, compared to CLBT's ROE of -0.81%. Regarding short-term risk, HCP is less volatile compared to CLBT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CLBT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TENB has a market cap of 3.6B. Regarding current trading prices, HCP is priced at $34.78, while TENB trades at $29.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TENB's P/E ratio is -80.51. In terms of profitability, HCP's ROE is -0.07%, compared to TENB's ROE of -0.12%. Regarding short-term risk, HCP is less volatile compared to TENB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TENB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ODD has a market cap of 3.4B. Regarding current trading prices, HCP is priced at $34.78, while ODD trades at $58.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ODD's P/E ratio is 33.41. In terms of profitability, HCP's ROE is -0.07%, compared to ODD's ROE of +0.33%. Regarding short-term risk, HCP is less volatile compared to ODD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ODD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, HCP is priced at $34.78, while SWI trades at $18.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SWI's P/E ratio is 28.89. In terms of profitability, HCP's ROE is -0.07%, compared to SWI's ROE of +0.08%. Regarding short-term risk, HCP is more volatile compared to SWI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SWI's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AVPT has a market cap of 3.2B. Regarding current trading prices, HCP is priced at $34.78, while AVPT trades at $14.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AVPT's P/E ratio is -300.60. In terms of profitability, HCP's ROE is -0.07%, compared to AVPT's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to AVPT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AVPT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, HCP is priced at $34.78, while EVOP trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EVOP's P/E ratio is -309.00. In terms of profitability, HCP's ROE is -0.07%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to EVOP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVOP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DOCN has a market cap of 2.8B. Regarding current trading prices, HCP is priced at $34.78, while DOCN trades at $30.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DOCN's P/E ratio is 23.71. In terms of profitability, HCP's ROE is -0.07%, compared to DOCN's ROE of -0.63%. Regarding short-term risk, HCP is less volatile compared to DOCN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOCN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, WRD has a market cap of 2.8B. Regarding current trading prices, HCP is priced at $34.78, while WRD trades at $9.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas WRD's P/E ratio is -8.34. In terms of profitability, HCP's ROE is -0.07%, compared to WRD's ROE of -0.61%. Regarding short-term risk, HCP is less volatile compared to WRD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WRD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, MQ has a market cap of 2.8B. Regarding current trading prices, HCP is priced at $34.78, while MQ trades at $6.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas MQ's P/E ratio is -47.69. In terms of profitability, HCP's ROE is -0.07%, compared to MQ's ROE of +0.05%. Regarding short-term risk, HCP is less volatile compared to MQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MQ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PAGS has a market cap of 2.8B. Regarding current trading prices, HCP is priced at $34.78, while PAGS trades at $8.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PAGS's P/E ratio is 6.89. In terms of profitability, HCP's ROE is -0.07%, compared to PAGS's ROE of +0.15%. Regarding short-term risk, HCP is less volatile compared to PAGS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAGS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZW has a market cap of 2.5B. Regarding current trading prices, HCP is priced at $34.78, while CORZW trades at $7.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CORZW's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.07%, compared to CORZW's ROE of +1.54%. Regarding short-term risk, HCP is less volatile compared to CORZW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PGY has a market cap of 2.5B. Regarding current trading prices, HCP is priced at $34.78, while PGY trades at $33.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PGY's P/E ratio is -8.41. In terms of profitability, HCP's ROE is -0.07%, compared to PGY's ROE of -0.90%. Regarding short-term risk, HCP is less volatile compared to PGY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PGY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PAYO has a market cap of 2.4B. Regarding current trading prices, HCP is priced at $34.78, while PAYO trades at $6.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PAYO's P/E ratio is 26.92. In terms of profitability, HCP's ROE is -0.07%, compared to PAYO's ROE of +0.13%. Regarding short-term risk, HCP is less volatile compared to PAYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAYO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EVTC has a market cap of 2.4B. Regarding current trading prices, HCP is priced at $34.78, while EVTC trades at $37.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EVTC's P/E ratio is 17.26. In terms of profitability, HCP's ROE is -0.07%, compared to EVTC's ROE of +0.26%. Regarding short-term risk, HCP is less volatile compared to EVTC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVTC's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PGYWW has a market cap of 2.3B. Regarding current trading prices, HCP is priced at $34.78, while PGYWW trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PGYWW's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.07%, compared to PGYWW's ROE of -0.90%. Regarding short-term risk, HCP is less volatile compared to PGYWW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PGYWW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, APPN has a market cap of 2.2B. Regarding current trading prices, HCP is priced at $34.78, while APPN trades at $29.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas APPN's P/E ratio is -128.83. In terms of profitability, HCP's ROE is -0.07%, compared to APPN's ROE of +1.51%. Regarding short-term risk, HCP is less volatile compared to APPN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check APPN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, BB has a market cap of 2.2B. Regarding current trading prices, HCP is priced at $34.78, while BB trades at $3.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas BB's P/E ratio is 183.00. In terms of profitability, HCP's ROE is -0.07%, compared to BB's ROE of -0.06%. Regarding short-term risk, HCP is less volatile compared to BB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while GETVV trades at $2.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GETVV's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.07%, compared to GETVV's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GETVV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GETVV's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while AVDX trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AVDX's P/E ratio is -248.00. In terms of profitability, HCP's ROE is -0.07%, compared to AVDX's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to AVDX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AVDX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FIVN has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while FIVN trades at $25.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FIVN's P/E ratio is 217.00. In terms of profitability, HCP's ROE is -0.07%, compared to FIVN's ROE of +0.01%. Regarding short-term risk, HCP is less volatile compared to FIVN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FIVN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TDC has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while TDC trades at $21.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TDC's P/E ratio is 18.66. In terms of profitability, HCP's ROE is -0.07%, compared to TDC's ROE of +0.74%. Regarding short-term risk, HCP is less volatile compared to TDC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TDC's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EVCM has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while EVCM trades at $10.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EVCM's P/E ratio is -135.25. In terms of profitability, HCP's ROE is -0.07%, compared to EVCM's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to EVCM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVCM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while FORG trades at $23.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FORG's P/E ratio is -22.53. In terms of profitability, HCP's ROE is -0.07%, compared to FORG's ROE of -0.20%. Regarding short-term risk, HCP is less volatile compared to FORG. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FORG's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, HCP is priced at $34.78, while GSKY trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GSKY's P/E ratio is 18.61. In terms of profitability, HCP's ROE is -0.07%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, HCP is less volatile compared to GSKY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GSKY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CSGS has a market cap of 1.8B. Regarding current trading prices, HCP is priced at $34.78, while CSGS trades at $62.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CSGS's P/E ratio is 21.61. In terms of profitability, HCP's ROE is -0.07%, compared to CSGS's ROE of +0.29%. Regarding short-term risk, HCP is less volatile compared to CSGS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CSGS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, HCP is priced at $34.78, while GET trades at $1.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GET's P/E ratio is 31.33. In terms of profitability, HCP's ROE is -0.07%, compared to GET's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GET's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RAMP has a market cap of 1.7B. Regarding current trading prices, HCP is priced at $34.78, while RAMP trades at $25.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RAMP's P/E ratio is 140.24. In terms of profitability, HCP's ROE is -0.07%, compared to RAMP's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to RAMP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RAMP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while STER trades at $16.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas STER's P/E ratio is -98.47. In terms of profitability, HCP's ROE is -0.07%, compared to STER's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to STER. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STER's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NTCT has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while NTCT trades at $22.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NTCT's P/E ratio is 21.76. In terms of profitability, HCP's ROE is -0.07%, compared to NTCT's ROE of +0.05%. Regarding short-term risk, HCP is less volatile compared to NTCT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTCT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while ZUO trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ZUO's P/E ratio is -19.65. In terms of profitability, HCP's ROE is -0.07%, compared to ZUO's ROE of -0.31%. Regarding short-term risk, HCP is less volatile compared to ZUO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZUO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while SUMO trades at $12.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SUMO's P/E ratio is -11.36. In terms of profitability, HCP's ROE is -0.07%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, HCP is more volatile compared to SUMO. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SUMO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GB has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while GB trades at $7.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GB's P/E ratio is 18.27. In terms of profitability, HCP's ROE is -0.07%, compared to GB's ROE of +0.76%. Regarding short-term risk, HCP is less volatile compared to GB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TUYA has a market cap of 1.4B. Regarding current trading prices, HCP is priced at $34.78, while TUYA trades at $2.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TUYA's P/E ratio is 59.25. In terms of profitability, HCP's ROE is -0.07%, compared to TUYA's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to TUYA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TUYA's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RPD has a market cap of 1.4B. Regarding current trading prices, HCP is priced at $34.78, while RPD trades at $20.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RPD's P/E ratio is 48.34. In terms of profitability, HCP's ROE is -0.07%, compared to RPD's ROE of +0.66%. Regarding short-term risk, HCP is less volatile compared to RPD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RPD's competition here